Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab-Reference-Cited by-同舟云学术

Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab

Published:2021-08-21 Issue:2 Volume:181 Page:539-547
ISSN:0340-6199
Container-title:European Journal of Pediatrics
language:en
Short-container-title:Eur J Pediatr

Author:

Chida-Nagai Ayako,Sato Hiroki,Sato Itsumi,Shiraishi Masahiro,Sasaki Daisuke,Izumi Gaku,Yamazawa Hirokuni,Cho Kazutoshi,Manabe Atsushi,Takeda Atsuhito^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s00431-021-04216-7.pdf

Reference14 articles.

1. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D et al (2009) The burden of respiratory syncytial virus infection in young children. N Eng J Med 36:588–598. https://doi.org/10.1056/nejmoa0804877

2. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N et al (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545–1555. https://doi.org/10.1016/S0140-6736(10)60206-1

3. Krzyzaniak MA, Zumstein MT, Gerez JA, Picotti P, Helenius A (2013) Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog 9:e1003309. https://doi.org/10.1371/journal.ppat.1003309

4. Zhao M, Zheng ZZ, Chen M, Modjarrad K, Zhang W, Zhan LT, Cao JL, Sun YP, McLellan JS, Graham BS et al (2017) Discovery of a prefusion respiratory syncytial virus F-specific monoclonal antibody that provides greater in vivo protection than the murine precursor of palivizumab. J Virol 91:e00176-e217. https://doi.org/10.1128/JVI.00176-17

5. Kusuda S, Takahashi N, Saitoh T, Terai M, Kaneda H, Kato Y, Ohashi A, Watabe S, Joh-o K, Hirai K (2011) Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high-risk infants in Japan. Pediatr Int 53:368–373. https://doi.org/10.1111/j.1442-200X.2010.03249.x

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory Syncytial Virus, Influenza and SARS-CoV-2 in Homeless People from Urban Shelters: A Systematic Review and Meta-Analysis (2023);Epidemiologia;2024-01-31

2. Efficacy and safety of respiratory syncytial virus vaccination during pregnancy to prevent lower respiratory tract illness in newborns and infants: a systematic review and meta-analysis of randomized controlled trials;Frontiers in Pediatrics;2024-01-31

3. Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000–2022);Children;2023-07-05

4. Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians;Pediatric Reports;2023-02-20

5. Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge;Vaccines;2022-12-05